Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: The prospective Crohn’s Disease Clinical Network and Cohort Study is a nationwide multicenter cohort study of patients with Crohn’s disease (CD) in Korea, aiming to prospectively investigate the clinical features and long-term prognosis associated with CD. Methods: Patients diagnosed with CD between January 2009 and September 2019 were prospectively enrolled. They were divided into two cohorts according to the year of diagnosis: cohort 1 (diagnosed between 2009 and 2011) versus cohort 2 (between 2012 and 2019). Results: A total of 1,175 patients were included, and the median follow-up duration was 68 months (interquartile range, 39.0 to 91.0 months). The treatment-free durations for thiopurines (p<0.001) and anti-tumor necrosis factor agents (p=0.018) of cohort 2 were shorter than those of cohort 1. Among 887 patients with B1 behavior at diagnosis, 149 patients (16.8%) progressed to either B2 or B3 behavior during follow-up. Early use of thiopurine was associated with a reduced risk of behavioral progression (adjusted hazard ratio [aHR], 0.69; 95% confidence interval [CI], 0.50 to 0.90), and family history of inflammatory bowel disease was associated with an increased risk of behavioral progression (aHR, 2.29; 95% CI, 1.16 to 4.50). One hundred forty-one patients (12.0%) underwent intestinal resection, and the intestinal resection-free survival time was significantly longer in cohort 2 than in cohort 1 (p=0.003). The early use of thiopurines (aHR, 0.35; 95% CI, 0.23 to 0.51) was independently associated with a reduced risk of intestinal resection. Conclusions: The prognosis of CD in Korea appears to have improved over time, as evidenced by the decreasing intestinal resection rate. Early use of thiopurines was associated with an improved prognosis represented by a reduced risk of intestinal resection.
Abstract
Background/Aims: The prospective Crohn’s Disease Clinical Network and Cohort Study is a nationwide multicenter cohort study of patients with Crohn’s disease (CD) in Korea, aiming to prospectively investigate the clinical features and long-term prognosis associated with CD. Methods: Patients diagnosed with CD between January 2009 and September 2019 were prospectively enrolled. They were divided into two cohorts according to the year of diagnosis: cohort 1 (diagnosed between 2009 and 2011) versus cohort 2 (between 2012 and 2019). Results: A total of 1,175 patients were included, and the median follow-up duration was 68 months (interquartile range, 39.0 to 91.0 months). The treatment-free durations for thiopurines (p<0.001) and anti-tumor necrosis factor agents (p=0.018) of cohort 2 were shorter than those of cohort 1. Among 887 patients with B1 behavior at diagnosis, 149 patients (16.8%) progressed to either B2 or B3 behavior during follow-up. Early use of thiopurine was associated with a reduced risk of behavioral progression (adjusted hazard ratio [aHR], 0.69; 95% confidence interval [CI], 0.50 to 0.90), and family history of inflammatory bowel disease was associated with an increased risk of behavioral progression (aHR, 2.29; 95% CI, 1.16 to 4.50). One hundred forty-one patients (12.0%) underwent intestinal resection, and the intestinal resection-free survival time was significantly longer in cohort 2 than in cohort 1 (p=0.003). The early use of thiopurines (aHR, 0.35; 95% CI, 0.23 to 0.51) was independently associated with a reduced risk of intestinal resection. Conclusions: The prognosis of CD in Korea appears to have improved over time, as evidenced by the decreasing intestinal resection rate. Early use of thiopurines was associated with an improved prognosis represented by a reduced risk of intestinal resection.
참고문헌 (56)
- Torres J, "Crohn’s disease", Lancet, 389, pp.1741~1755 (2017)
- Emiko Mizoguchi, "Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models", Intestinal research, 18(2), pp.151~167 (2020), 대한장연구학회[DOI]
- Yang SK, "Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005 : a KASID study", Inflamm Bowel Dis, 14, pp.542~549 (2008)
- Ng SC, "Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century : a systematic review of population-based studies", Lancet, 390, pp.2769~2778 (2017)
- Park SH, "A 30-year trend analysis in the epidemiology of inflammatory bowel disease in the Songpa-Kangdong district of Seoul, Korea in 1986-2015", J Crohns Colitis, 13, pp.1410~1417 (2019)
- Hsu-Heng Yen, "Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide population-based study", Intestinal research, 17(1), pp.54~62 (2019), 대한장연구학회[DOI]
- GBD 2017 Inflammatory Bowel Disease Collaborators, "The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017 : a systematic analysis for the Global Burden of Disease Study 2017", Lancet Gastroenterol Hepatol, 5, pp.17~30 (2020)
- Jamilya Kaibullayeva, "Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study", Intestinal research, 18(4), pp.430~437 (2020), 대한장연구학회[DOI]
- Ajit Sood, "Trends of inflammatory bowel disease at a tertiary care center in northern India", Intestinal research, 19(3), pp.282~290 (2021), 대한장연구학회[DOI]
- Mao EJ, "Systematic review with meta-analysis : comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn’s disease and ulcerative colitis", Aliment Pharmacol Ther, 45, pp.3~13 (2017)
- Frei R, "Early initiation of anti-TNF is associated with favourable long-term outcome in Crohn’s disease : 10-year-follow-up data from the Swiss IBD cohort study", J Crohns Colitis, 13, pp.1292~1301 (2019)
- 천재희, "Crohn’s Disease Clinical Network and Cohort (CONNECT) Study: The First Step Toward Nationwide Multicenter Research of Crohn’s Disease in Korea", Intestinal research, 12(3), pp.173~175 (2014), 대한장연구학회
- Jung YS, "Long-term clinical outcomes of urban versus rural environment in Korean patients with Crohn’s disease : results from the CONNECT study", J Crohns Colitis, 9, pp.246~251 (2015)
- Kim B, "Crohn’s disease prognosis and early immunomodulator therapy : results from the CONNECT study", J Gastroenterol Hepatol, 31, pp.126~132 (2016)
- 권지혜, "Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn’s Disease: Results from the CONNECT Study", Gut and Liver, 10(4), pp.595~603 (2016), 거트앤리버 소화기연관학회협의회
- Park Y, "Development of a novel predictive model for the clinical course of Crohn’s disease : results from the CONNECT study", Inflamm Bowel Dis, 23, pp.1071~1079 (2017)
- Silverberg MS, "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology", Can J Gastroenterol, 19(Suppl A), pp.5A~36A (2005)
- Loftus EV Jr, "Crohn’s disease in Olmsted County, Minnesota, 1940-1993 : incidence, prevalence, and survival", Gastroenterology, 114, pp.1161~1168 (1998)
- Lee YJ, "Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn’s disease", Endoscopy, 38, pp.592~597 (2006)
- Ramadas AV, "Natural history of Crohn’s disease in a population-based cohort from Cardiff(1986-2003) : a study of changes in medical treatment and surgical resection rates", Gut, 59, pp.1200~1206 (2010)
- Park SH, "Long-term prognosis of Crohn’s disease and its temporal change between 1981 and 2012 : a hospital-based cohort study from Korea", Inflamm Bowel Dis, 20, pp.488~494 (2014)
- Lakatos PL, "Has there been a change in the natural history of Crohn’s disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009", Am J Gastroenterol, 107, pp.579~588 (2012)
- Noh SM, "Association of faecal calprotectin level and combined endoscopic and radiological healing in patients with Crohn’s disease receiving anti-tumour necrosis factor therapy", J Crohns Colitis, 14, pp.1231~1240 (2020)
- Burisch J, "Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort : an Epi-IBD study", Gut, 68, pp.423~433 (2019)
- Oriuchi T, "Clinical course and longterm prognosis of Japanese patients with Crohn’s disease : predictive factors, rates of operation, and mortality", J Gastroenterol, 38, pp.942~953 (2003)
- Ye BD, "Clinical features and longterm prognosis of Crohn’s disease in Korea", Scand J Gastroenterol, 45, pp.1178~1185 (2010)
- Zeng Z, "Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China : a prospective populationbased study", J Gastroenterol Hepatol, 28, pp.1148~1153 (2013)
- Kim HJ, "Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012 : a nationwide population-based study", Inflamm Bowel Dis, 21, pp.623~630 (2015)
- Yang SK, "How does the epidemiology of inflammatory bowel disease differ between east and west? A Korean perspective", Inflamm Intest Dis, 2, pp.95~101 (2017)
- Ajit Sood, "Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry", Intestinal research, 19(2), pp.206~216 (2021), 대한장연구학회[DOI]
- Moon CM, "Clinical features and predictors of clinical outcomes in Korean patients with Crohn's disease : a Korean association for the study of intestinal diseases multicenter study", J Gastroenterol Hepatol, 29, pp.74~82 (2014)
- Jeuring SF, "Improvements in the long-term outcome of Crohn’s disease over the past two decades and the relation to changes in medical management : results from the population-based IBDSL cohort", Am J Gastroenterol, 112, pp.325~336 (2017)
- Hampe J, "Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations", Lancet, 357, pp.1925~1928 (2001)
- Ogura Y, "A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease", Nature, 411, pp.603~606 (2001)
- Economou M, "Differential effects of NOD2 variants on Crohn’s disease risk and phenotype in diverse populations : a metaanalysis", Am J Gastroenterol, 99, pp.2393~2404 (2004)
- Ng SC, "Genetics of inflammatory bowel disease in Asia : systematic review and meta-analysis", Inflamm Bowel Dis, 18, pp.1164~1176 (2012)
- Liu JZ, "Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations", Nat Genet, 47, pp.979~986 (2015)
- Yang SK, "Association of TNFSF15with Crohn’s disease in Koreans", Am J Gastroenterol, 103, pp.1437~1442 (2008)
- Yamazaki K, "A genomewide association study identifies 2 susceptibility Loci for Crohn’s disease in a Japanese population", Gastroenterology, 144, pp.781~788 (2013)
- Abreu MT, "Mutations in NOD2are associated with fibrostenosing disease in patients with Crohn’s disease", Gastroenterology, 123, pp.679~688 (2002)
- Hampe J, "Association of NOD2(CARD 15)genotype with clinical course of Crohn’s disease : a cohort study", Lancet, 359, pp.1661~1665 (2002)
- Yang DH, "TNFSF15 is an independent predictor for the development of Crohn’s disease-related complications in Koreans", J Crohns Colitis, 8, pp.1315~1326 (2014)
- Thia KT, "Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort", Gastroenterology, 139, pp.1147~1155 (2010)
- Trier Moller F, "Hospital admissions, biological therapy, and surgery in familial and sporadic cases of inflammatory bowel disease : a population-based cohort study 1977-2011", Inflamm Bowel Dis, 21, pp.2825~2832 (2015)
- Hwang SW, "Influence of a positive family history on the clinical course of inflammatory bowel disease", J Crohns Colitis, 10, pp.1024~1032 (2016)
- Ye Byong Duk, "Changes in the Long-term Prognosis of Crohn’s Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study", Gut and Liver, 16(2), pp.216~227 (2022), 거트앤리버 소화기연관학회협의회[DOI]
- Rungoe C, "Changes in medical treatment and surgery rates in inflammatory bowel disease : a nationwide cohort study 1979-2011", Gut, 63, pp.1607~1616 (2014)
- Cosnes J, "Early administration of azathioprine vs conventional management of Crohn’s disease : a randomized controlled trial", Gastroenterology, 145, pp.758~765 (2013)
- Murthy SK, "Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases : a population-based interrupted time series study", Gut, 69, pp.274~282 (2020)
- Frolkis AD, "Risk of surgery for inflammatory bowel diseases has decreased over time : a systematic review and meta-analysis of population-based studies", Gastroenterology, 145, pp.996~1006 (2013)
- Beelen EM, "Intestinal resection rates in Crohn’s disease decline across two different epidemiological areas : a consistent observation not merely due to introduction of anti-TNFα", Gut, 69, pp.1~ (2020)
- Seo H, "Long-term outcomes of adalimumab treatment in 254 patients with Crohn’s disease : a hospital-based cohort study from Korea", Dig Dis Sci, 62, pp.2882~2893 (2017)
- Hanauer SB, "Crohn’s disease : step up or top down therapy", Best Pract Res Clin Gastroenterol, 17, pp.131~137 (2003)
- 예병덕, "크론병 치료 가이드라인", 대한소화기학회지, 59(2), pp.141~179 (2012), 대한소화기학회
- 박재준, "Second Korean guidelines for the management of Crohn’s disease", Intestinal research, 15(1), pp.38~67 (2017), 대한장연구학회
- Choon Jin Ooi, "Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia", Intestinal research, 17(3), pp.285~310 (2019), 대한장연구학회[DOI]